A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C

Authors:

Abstract
In our search for the mechanisms by which the drug 1‐O‐alkyl‐2‐O‐methylglycero‐3‐phosphocholine (AMG‐PC) inhibits tumor growth and metastasis, we have detected a metabolite, 1‐O‐alkyl‐2‐O‐methylglycerol (AMG), in membranes of MO4 mouse fibrosarcoma cells grown in the presence of the drug. Synthetic AMG inhibited the activation of highly purified human protein kinase C by diacylglycerol in the presence of phosphatidylserine. Furthermore, AMG also inhibited the receptor‐specific binding of3H‐phorbol‐12,13‐dibutyrate to human HL‐60 promyeloid leukemia cells in a dose‐dependent fashion. AMG‐PC was not effective or much less so in these assays. We suggest that interaction of the metabolite AMG with protein kinase C may inhibit stimulus‐response coupling in tumor cells and may thus potentially contribute to the mechanism by which AMG‐PC exerts its anticancer activities.

This publication has 20 references indexed in Scilit: